StockData
ProMIS Neurosciences Inc. logo

ProMIS Neurosciences Inc. (PMN) stock

PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$3.31+0.02 (+0.61%)

Close on Nov 16, 2026Market cap $29.68MP/E –Yield –

ProMIS Neurosciences total assets

Total assets on the balance sheet at the end of each period.

ProMIS Neurosciences's total assets was $56.69M at Jun 30, 2026. For fiscal 2025 it was $9.18M, down 51.4% from the year before. The highest annual figure on record is $18.91M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.18M-51.4%
FY2024Dec 31, 2024$18.91M+38.9%
FY2023Dec 31, 2023$13.62M+96.7%
FY2022Dec 31, 2022$6.92M-61.0%
FY2021Dec 31, 2021$17.75M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$56.69M+496.2%
Q1 FY2026Mar 31, 2026$67.41M+394.0%
Q4 FY2025Dec 31, 2025$9.18M-51.4%
Q3 FY2025Sep 30, 2025$21.46M-12.5%
Q2 FY2025Jun 30, 2025$9.51M+574.6%
Q1 FY2025Mar 31, 2025$13.65M+284.6%
Q4 FY2024Dec 31, 2024$18.91M+38.9%
Q3 FY2024Sep 30, 2024$24.51M+37.1%
Q2 FY2024Jun 30, 2024$1.41M-5.9%
Q1 FY2024Mar 31, 2024$3.55M-19.9%
Q4 FY2023Dec 31, 2023$13.62M+96.7%
Q3 FY2023Sep 30, 2023$17.88M+232.2%
Q2 FY2023Jun 30, 2023$1.50M-85.3%
Q1 FY2023Mar 31, 2023$4.43M-75.0%
Q4 FY2022Dec 31, 2022$6.92M–
Q3 FY2022Sep 30, 2022$5.38M–
Q2 FY2022Jun 30, 2022$10.19M–
Q4 FY2021Dec 31, 2021$17.75M–

More ProMIS Neurosciences figures

See a number that looks wrong?